Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of the combination of bone morphogenetic protein-2 and nano-hydroxyapatite on the osseointegration of dental implants

  • Pang, KangMi (Department of Dentistry, Oral and Maxillofacial Surgery, Seoul National University Dental Hospital) ;
  • Seo, Young-Kwon (Department of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University) ;
  • Lee, Jong-Ho (Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University)
  • Received : 2021.10.15
  • Accepted : 2021.10.21
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study aimed to investigate the in vitro osteoinductivity of the combination of bone morphogenetic protein-2 (BMP-2) and nanohydroxyapatite (nHAp) and the in vivo effects of implants coated with nHAp/BMP-2. Materials and Methods: To evaluate the in vitro efficacy of nHAp/BMP-2 on bone formation, bone marrow-derived mesenchymal stem cells (BM-MSCs) were seeded onto titanium disks coated with collagen (Col), Col/nHAp, or Col/nHAp/BMP-2. Protein levels were determined by a biochemical assay and reverse transcriptase-polymerase chain reaction. Stem cell differentiation was analyzed by flow cytometry. For in vivo studies with mice, Col, Col/nHAp, and Col/nHAp/BMP-2 were injected in subcutaneous pockets. Titanium implants or implants coated with Col/nHAp/BMP-2 were placed bilaterally on rabbit tibias and evaluated for 4 weeks. Results: In the in vitro study, BM-MSCs on Col/nHAp/BMP-2 showed reduced levels of CD73, CD90, and CD105 and increased levels of glycosaminoglycan, osteopontin, and alkaline phosphatase activity. After 4 weeks, the Col/nHAp/BMP-2 implant showed greater bone formation than the control (P=0.07), while no differences were observed in bone implant contact and removal torque. Conclusion: These results suggest that a combination of BMP-2 and an nHAp carrier would activate osseointegration on dental implant surfaces.

Keywords

References

  1. Coelho PG, Granjeiro JM, Romanos GE, Suzuki M, Silva NR, Cardaropoli G, et al. Basic research methods and current trends of dental implant surfaces. J Biomed Mater Res B Appl Biomater 2009;88:579-96. https://doi.org/10.1002/jbm.b.31264
  2. Dohan Ehrenfest DM, Coelho PG, Kang BS, Sul YT, Albrektsson T. Classification of osseointegrated implant surfaces: materials, chemistry and topography. Trends Biotechnol 2010;28:198-206. https://doi.org/10.1016/j.tibtech.2009.12.003
  3. Mendonca G, Mendonca DB, Aragao FJ, Cooper LF. Advancing dental implant surface technology--from micron- to nanotopography. Biomaterials 2008;29:3822-35. https://doi.org/10.1016/j.biomaterials.2008.05.012
  4. Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Nishimura R, Wozney JM, et al. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003;14:793-803. https://doi.org/10.1046/j.0905-7161.2003.clr140617.x
  5. Park JC, Kim JC, Kim BK, Cho KS, Im GI, Kim BS, et al. Doseand time-dependent effects of recombinant human bone morphogenetic protein-2 on the osteogenic and adipogenic potentials of alveolar bone-derived stromal cells. J Periodontal Res 2012;47:645-54. https://doi.org/10.1111/j.1600-0765.2012.01477.x
  6. Lee JH, Yu CH, Yang JJ, Baek HR, Lee KM, Koo TY, et al. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Spine J 2012;12:239-48. https://doi.org/10.1016/j.spinee.2012.01.013
  7. Fujimura K, Bessho K, Kusumoto K, Ogawa Y, Iizuka T. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 1995;208:316-22. https://doi.org/10.1006/bbrc.1995.1340
  8. Garrett MP, Kakarla UK, Porter RW, Sonntag VK. Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions. Neurosurgery 2010;66:1044-9; discussion 1049. https://doi.org/10.1227/01.NEU.0000369517.21018.F2
  9. Kokorina NA, Lewis JS Jr, Zakharkin SO, Krebsbach PH, Nussenbaum B. rhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo. Laryngoscope 2012;122:95-102. https://doi.org/10.1002/lary.22345
  10. Koyama N, Okubo Y, Nakao K, Osawa K, Bessho K. Experimental study of osteoinduction using a new material as a carrier for bone morphogenetic protein-2. Br J Oral Maxillofac Surg 2011;49:314-8. https://doi.org/10.1016/j.bjoms.2010.05.010
  11. Mindea SA, Shih P, Song JK. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine (Phila Pa 1976) 2009;34:1480-4; discussion 1485. https://doi.org/10.1097/BRS.0b013e3181a396a1
  12. Perri B, Cooper M, Lauryssen C, Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 2007;7:235-9. https://doi.org/10.1016/j.spinee.2006.04.010
  13. Smoljanovic T, Pecina M. Re: Burkus J K, Sandhu H S, Gornet M F. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine 2006;31:775-81. Spine (Phila Pa 1976) 2008;33:226. https://doi.org/10.1097/BRS.0b013e3181606894
  14. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008;8:1011-8. https://doi.org/10.1016/j.spinee.2007.06.014
  15. Wen B, Karl M, Pendrys D, Shafer D, Freilich M, Kuhn L. An evaluation of BMP-2 delivery from scaffolds with miniaturized dental implants in a novel rat mandible model. J Biomed Mater Res B Appl Biomater 2011;97:315-26. https://doi.org/10.1002/jbm.b.31817
  16. Zhang W, Tsurushima H, Oyane A, Yazaki Y, Sogo Y, Ito A, et al. BMP-2 gene-fibronectin-apatite composite layer enhances bone formation. J Biomed Sci 2011;18:62. https://doi.org/10.1186/1423-0127-18-62
  17. Hulsart-Billstrom G, Hu Q, Bergman K, Jonsson KB, Aberg J, Tang R, et al. Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: a study on ectopic bone formation in rats. Acta Biomater 2011;7:3042-9. https://doi.org/10.1016/j.actbio.2011.04.021
  18. Li J, Li Y, Ma S, Gao Y, Zuo Y, Hu J. Enhancement of bone formation by BMP-7 transduced MSCs on biomimetic nano-hydroxyapatite/polyamide composite scaffolds in repair of mandibular defects. J Biomed Mater Res A 2010;95:973-81. https://doi.org/10.1002/jbm.a.32926
  19. Liu Y, Lu Y, Tian X, Cui G, Zhao Y, Yang Q, et al. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 2009;30:6276-85. https://doi.org/10.1016/j.biomaterials.2009.08.003
  20. Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, et al. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995;41:1560-6. https://doi.org/10.1093/clinchem/41.11.1560
  21. Salbach J, Rachner TD, Rauner M, Hempel U, Anderegg U, Franz S, et al. Regenerative potential of glycosaminoglycans for skin and bone. J Mol Med (Berl) 2012;90:625-35. https://doi.org/10.1007/s00109-011-0843-2
  22. Chen J, Singh K, Mukherjee BB, Sodek J. Developmental expression of osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone formation and resorption. Matrix 1993;13:113-23. https://doi.org/10.1016/s0934-8832(11)80070-3
  23. Prosecka E, Rampichova M, Vojtova L, Tvrdik D, Melcakova S, Juhasova J, et al. Optimized conditions for mesenchymal stem cells to differentiate into osteoblasts on a collagen/hydroxyapatite matrix. J Biomed Mater Res A 2011;99:307-15. https://doi.org/10.1002/jbm.a.33189
  24. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456-69. https://doi.org/10.1016/j.cell.2007.05.047
  25. Blazquez-Medela AM, Lopez-Novoa JM, Martinez-Salgado C. Osteoprotegerin and diabetes-associated pathologies. Curr Mol Med 2011;11:401-16. https://doi.org/10.2174/156652411795976565
  26. Marks SC Jr, Odgren PR. Chapter 1 - structure and development of the skeleton. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. 2nd ed. New York (NY): Academic Press; 2002:3-15.
  27. Liu X, Wu H, Byrne M, Krane S, Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A 1997;94:1852-6. https://doi.org/10.1073/pnas.94.5.1852
  28. Song DS, Park JC, Jung IH, Choi SH, Cho KS, Kim CK, et al. Enhanced adipogenic differentiation and reduced collagen synthesis induced by human periodontal ligament stem cells might underlie the negative effect of recombinant human bone morphogenetic protein-2 on periodontal regeneration. J Periodontal Res 2011;46:193-203. https://doi.org/10.1111/j.1600-0765.2010.01328.x
  29. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29. https://doi.org/10.1016/s0092-8674(01)00622-5
  30. Shi S, Cheng X, Wang J, Zhang W, Peng L, Zhang Y. RhBMP-2 microspheres-loaded chitosan/collagen scaffold enhanced osseointegration: an experiment in dog. J Biomater Appl 2009;23:331-46. https://doi.org/10.1177/0885328208090013
  31. Chatzinikolaidou M, Lichtinger TK, Muller RT, Jennissen HP. Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers. Acta Biomater 2010;6:4405-21. https://doi.org/10.1016/j.actbio.2010.06.009
  32. Lan J, Wang ZF, Shi B, Xia HB, Cheng XR. The influence of recombinant human BMP-2 on bone-implant osseointegration: biomechanical testing and histomorphometric analysis. Int J Oral Maxillofac Surg 2007;36:345-9. https://doi.org/10.1016/j.ijom.2006.10.019
  33. Bae IH, Yun KD, Kim HS, Jeong BC, Lim HP, Park SW, et al. Anodic oxidized nanotubular titanium implants enhance bone morphogenetic protein-2 delivery. J Biomed Mater Res B Appl Biomater 2010;93:484-91. https://doi.org/10.1002/jbm.b.31606
  34. Shi J, Dong LL, He F, Zhao S, Yang GL. Osteoblast responses to thin nanohydroxyapatite coated on roughened titanium surfaces deposited by an electrochemical process. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:e311-6. https://doi.org/10.1016/j.oooo.2012.02.021